|
|
Office Locations:
|
430 Park Avenue, 18th Floor
New York, NY 10022
Phone: 212-826-2700
Fax: 646-217-3691
| | |
|
|
|
|
|
Electronics & Advanced Materials
Life Sciences & Healthcare
Manufacturing & Industrial
|
|
|
|
SK Capital is a private investment firm with a disciplined focus on the specialty materials, chemicals and healthcare sectors. Located in New York, NY and Boca Raton, FL, the firm is currently investing from SK Capital Partners III, L.P., a $1.5 billion fund of committed capital. SK's portfolio companies generate revenues of over $11 billion annually and employ more than 15,000 people. SK Capital seeks buyouts, recapitalizations and growth equity investments, targeting companies currently generating strong growth and/or profitability, as well as those with complexity, significant liabilities, operational underperformance or management gaps. SK Capital typically invests equity of $100 million to $200 million in each portfolio company.
|
|
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
